This clinical trial evaluates the feasibility of a linguistically-tailored mobile intervention, called CervixChat in improving the follow-up of patients with abnormal Papanicolaou (pap) test results. A text messaging program, such as CervixChat may support patients who need a colposcopy.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04821297.
PRIMARY OBJECTIVE:
I. To evaluate the feasibility of CervixChat intervention in a mix method design, through participants consent rate and the study completion rate.
SECONDARY OBJECTIVE:
I. To evaluate the acceptability of CervixChat intervention using a validated Likert-scale participant satisfaction questionnaire, as well as participant’s interview data.
EXPLORATORY OBJECTIVE:
I. To evaluate the preliminary impact of CervixChat intervention, by comparing the colposcopy appointment adherence rate in the study cohort against a 1:1 matched control sample selected based on matching age, race and ethnicity, from participants at Jefferson Obstetrics and Gynecology (Ob-Gyn) department scheduled for a colposcopy in 2019.
OUTLINE:
Patients receive text messages for 1-2 months before scheduled appointment. Patients also complete a survey at baseline and after standard of care colposcopy and an interview after standard of care colposcopy.
After completion of study, patients are followed up periodically.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationThomas Jefferson University Hospital
Principal InvestigatorKuang-Yi Wen
